Idogen invited by GJCF to participate in their 3[rd] Summit for NMOSD Tolerization
Today, Idogen AB informed of their special invitation and participation as one of only 10 companies in The Guthy Jackson Charitable Foundation (GJCF) 3rd Summit for NMOSD Tolerization at the University of California, Los Angeles that took part 20-22 January. The companies represented a variety of tolerization technology platforms within autoimmune disorders. In addition to GJCF leaders, 15 world-leading key opinion leaders and experts in the area of NMOSD and immune tolerance participated in the Summit. The Foundation is focused on novel solutions to the neuroinflammatory autoimmune